FDA approves new drug for deadly kidney cancer

(AP) -- A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news157655661.html">FDA approves new drug for deadly kidney cancer</a></p> <p>(AP) -- A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.</p>